Publications | Flatiron Health | Artificial intelligence

Browse every publication tagged Artificial intelligence

November 2026
When MRD matters: clinical interpretation and treatment decision-making after measurable residual disease testing in multiple myeloma
November 2026
The CAR-T funnel: AI-assisted mapping of patient attrition and barriers across the second-line CAR-T pathway in relapsed/refractory diffuse large B-cell lymphoma
November 2026
Beyond treatment patterns: clinician-documented decision-making following dual BTK inhibitors and BCL2 inhibitor exposure in chronic lymphocytic leukemia
November 2026
Qualitative assessment of physician-documented drivers for switching covalent BTK inhibitors in CLL/SLL in real-world practice
October 2026
Extending the Validation of Accuracy for LLM–/ML–Extracted Information and Data (VALID) framework globally: Quality assessment of LLM-derived prostate cancer real-world data in the UK
October 2026
Leveraging large language models to characterize serious illness conversations in advanced non-small cell lung cancer
May 2026
From plenary to practice: A large language model (LLM)-based thematic analysis of landmark clinical trial discussions and factors influencing their real-world adoption
- Artificial intelligence
May 2026
Using ML to predict rapid progression for patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with frontline (1L) CDK 4/6 inhibitors (CDK 4/6i)
May 2026
Digital twin models for counterfactual prediction in NSCLC: a validation study using clinical trial data
- Artificial intelligence
- Lung cancer